Staged emulsification air assisted maturation and heated washing of poly L lactide microparticles for an injectable implant

This patent-based technical research article critically reconstructs and evaluates the process disclosed in Russian patent RU 2 816 188 C1 for producing poly(L-lactide) microparticles intended for an injectable implant. The process integrates cold capillary dispersion of PLLA in dichloromethane, air-assisted maturation, heated aqueous washing, centrifugation, and lyophilisation. Reported particle-size descriptors were re-analysed descriptively and compared with primary experimental literature, cited patent prior art, ICH residual-solvent and analytical-validation guidance, and ISO particle-size principles. The patent-reported data show a directional reduction in d50 from 67.51 to 13.80 µm across increasing agitation bands. The manuscript explicitly distinguishes reported results from derived calculations and prospective validation proposals. The available dossier does not establish quantitative absence of dichloromethane, inter-batch reproducibility, sterility, injectability, biological safety, or clinical effectiveness. A quality-by-design validation programme is proposed for further development.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-09
DOI
https://doi.org/10.5281/zenodo.23249824
Primary Topic
Advanced Drug Delivery Systems
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Staged emulsification air assisted maturation and heated washing of poly L lactide microparticles for an injectable implant

Ilyan Kan
Zenodo (CERN European Organization for Nuclear Research)
Advanced Drug Delivery Systems
preprint

Staged emulsification air assisted maturation and heated washing of poly L lactide microparticles for an injectable implant

Ilyan Kan
preprint en

Abstract

This patent-based technical research article critically reconstructs and evaluates the process disclosed in Russian patent RU 2 816 188 C1 for producing poly(L-lactide) microparticles intended for an injectable implant. The process integrates cold capillary dispersion of PLLA in dichloromethane, air-assisted maturation, heated aqueous washing, centrifugation, and lyophilisation. Reported particle-size descriptors were re-analysed descriptively and compared with primary experimental literature, cited patent prior art, ICH residual-solvent and analytical-validation guidance, and ISO particle-size principles. The patent-reported data show a directional reduction in d50 from 67.51 to 13.80 µm across increasing agitation bands. The manuscript explicitly distinguishes reported results from derived calculations and prospective validation proposals. The available dossier does not establish quantitative absence of dichloromethane, inter-batch reproducibility, sterility, injectability, biological safety, or clinical effectiveness. A quality-by-design validation programme is proposed for further development.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.